Socioeconomic characteristics of enrollees appear to influence performance scores for medicare part D contractors

Health Affairs

Volumn 33, Issue 1, 2014, Pages 140-146

  Young, Gary J ^a,b   Rickles, Nathaniel M ^b   Chou, Chia Hung ^c   Raver, Eli ^b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

ARTICLE; DRUG INDUSTRY; GOVERNMENT; HEALTH SERVICE; HUMAN; MEDICAID; MEDICARE; MEDICATION COMPLIANCE; POPULATION; SCORING SYSTEM; SOCIOECONOMICS; UNITED STATES; AGED; CONTRACT; ECONOMICS; HEALTH CARE COST; HEALTH CARE QUALITY; SOCIAL BEHAVIOR; STATISTICS AND NUMERICAL DATA;

AGED; CONTRACTS; HEALTH CARE COSTS; HUMANS; MEDICARE PART D; MEDICATION ADHERENCE; QUALITY ASSURANCE, HEALTH CARE; QUALITY INDICATORS, HEALTH CARE; SOCIAL RESPONSIBILITY; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84891811693     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2013.0261     Document Type: Article

References (25)

1. Frakt AB, Pizer SD. A first look at the new Medicare prescription drug plans. Health Aff (Millwood). 2006;25(4):w252-61. DOI: 10.1377/ hlthaff.25.w252.
2. Neuman P, Cubanski J. Medicare Part D update-lessons learned and unfinished business. N Engl J Med. 2009;361(4):406-14.
3. Centers for Medicare and Medicaid Services. Medicare health and drug plan quality and performance ratings: 2012 Part C and Part D technical notes. Baltimore (MD): CMS; updated 2012 Jan 18.
4. Henry Kaiser Family Foundation. Medicare Advantage plan star ratings and bonus payments in 2012 [Internet]. Menlo Park (CA): KFF; 2011 Nov [cited 2013 Dec 2]. (Data Brief). Available from: http:// kaiserfamilyfoundation.files.word press.com/2013/01/8257.pdf
5. Centers for Medicare and Medicaid Services. Medicare program; changes to the Medicare Advantage and the Medicare prescription drug benefit programs for contract year 2013 and other changes. Final rule with comment period. Fed Regist. 2012;77(71):22071-75.
6. CMS.gov. Part C and D performance data [Internet]. Baltimore (MD): Centers for Medicare and Medicaid Services; [last modified 2013 Oct 31; cited 2013 Dec 2]. Available from: http://www.cms.gov/Medicare/ Prescription-Drug-Coverage/ PrescriptionDrugCovGenIn/ PerformanceData.html
7. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353(3):487-97.
8. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002;36(9):1331-6.
9. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-30.
10. McCarthy R. The price you pay for the drug not taken. Bus Health. 1998;16(10):27-8, 30, 32-3.
11. Chan DC, Shrank WH, Cutler D, Jan S, Fischer MA, Liu J, et al. Patient, physician, and payment predictors of statin adherence. Med Care. 2010;48(3):196-202.
12. Peeters B, Van Tongelen I, Boussery K, Mehuys E, Remon JP, Willems S. Factors associated with medication adherence to oral hypoglycaemic agents in different ethnic groups suffering from type 2 diabetes: a systematic literature review and suggestions for further research. Diabet Med. 2011;28(3):262-75.
13. Lee CY, Huang CC, Shih HC, Huang KH. Factors influencing antihypertensive medication compliance in Taiwan: a nationwide populationbased study. Eur J Prev Cardiol. 2013;20(6):930-7.
14. Agency for Healthcare Research and Quality. CAHPS [home page on the Internet]. Rockville (MD): AHRQ; [last updated 2013 Jul 31; cited 2013 Dec 9]. Available from: https:// cahps.ahrq.gov/index.html
15. Zaslavsky AM, Epstein AM. How patients' sociodemographic characteristics affect comparisons of competing health plans in California on HEDIS quality measures. Int J Qual Health Care. 2005;17(1):67-74.
16. Trivedi AN, Zaslasvsky AM, Schneider EC, Ayanian JZ. Relationship between quality of care and racial disparities in Medicare health plans. JAMA. 2006;296(16): 1998-2004.
17. To access the Appendix, click on the Appendix link in the box to the right of the article online.
18. Center for Medicare Advocacy. Part D/prescription drug plan benefits [Internet].Willimantic (CT): The Center; [cited 2013 Dec 2]. Available from: http://www.medicareadvocacy .org/medicare-info/medicarepart- d/#LIS
19. Jung K, McBean AM, Kim JA. Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs. J Manag Care Pharm. 2012; 18(2):106-15.
20. Centers for Medicare and Medicaid Services. Roadmap for implementing value driven healthcare in the traditional Medicare fee-for-service program [Internet]. Baltimore (MD): CMS; [cited 2013 Dec 2]. Available from: http://www.cms .gov/Medicare/Quality-Initiatives- Patient-Assessment-Instruments/ QualityInitiativesGenInfo/ downloads/vbproadmap_oea_ 1-16_508.pdf
21. Chernew ME, Mechanic RE, Landon BE, Safran DG. Private-payer innovation in Massachusetts: the "Alternative Quality Contract." Health Aff (Millwood). 2011;30(1):51-61.
22. Casalino LP, Alexander GC, Jin L, Konetzka RT. General internists' views on pay-for-performance and public reporting of quality scores: a national survey. Health Aff (Millwood). 2007;26(2):492-9.
23. Romano PS. Should health plan quality measures be adjusted for case mix. Med Care. 2000;38(10): 977-80.
24. Berwick DM. The total customer relationship in health care: broadening the bandwidth. Jt Comm J Qual Improv. 1997;23(5):245-50.
25. Young GJ, Meterko M, Desai KR. Patient satisfaction with hospital care: effect of demographic and institutional characteristics. Med Care. 2000;38(3):325-34.